Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
doi:10.1126/science.1099191
For suspected DVT without breathing difficulties, contact your healthcare provider the same day for urgent assessment
doi: 10.2337/diacare.28.12.2948 Summary Keywords type 2 diabetes, tirzepatide, counterregulatory response, hypoglycemia, clinical trial Citation Pieber TR, Svehlikova E, Urva S, Haupt A, Zhou C, Coskun T, Hller V, Fluhr G, Karanikas CA, Milicevic Z and Pratt EJ (2025) Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide
They're only used if you choose to turn them on and may be set by us or by approved third-party partners.Cookie Details Functional cookies These cookies remember your choices, like your language or region, to make the website easier to use and more personalised for you
Providers evaluate: Body mass index (BMI) Existing medical conditions Current medications Gastrointestinal history Family history of endocrine tumors Pregnancy or breastfeeding status A personalized medical evaluation remains essential before starting any prescription weight-loss medication
